GLENBIO LTD

Company number NI610700 ·

Active

Executive summary

Glenbio Ltd exhibits strong financial health characterized by consistent organic growth, a robust equity base of £1.57M, and minimal long-term debt. The recent decline in cash reserves is entirely attributable to strategic capital expenditure on freehold property rather than operational shortcomings. With a healthy current ratio and strong retained earnings, the company presents a low credit risk and demonstrates sound financial stewardship by its directors.

Read the full AI analysis →

Shareholders' funds

£1,569,991

Balance sheet as at 2025-01-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2012-01-13
Employees
18 (2025 accounts)
Registered office
10 Kilbegs Road, Antrim, Northern Ireland, BT41 4NN
Postcode
BT41 4NN
Capital
100 GBP
Accounts category
Total Exemption Full
Charges
0 outstanding

Accounts

Last made up to
2025-01-31
Next due by
2026-10-31
Financial year end
31 January

Confirmation statement

Last statement dated
2026-07-22
Next due by
2027-08-05
View filing history →

Nature of business (SIC)

  • 20590 Manufacture of other chemical products not elsewhere classified

Officers 2 current

Appointed 2016-07-01
MR John MCINTOSH Director
Appointed 2012-01-13

View all officers and resignations →

Contact details

Website
glenbio.com

Glenbio is a Diagnostic Reagents Manufacturer, providing In Vitro Diagnostic reagents across various systems and platforms.

Previous registered addresses 2

AddressChanged on
21 HILLHEAD ROAD, TOOMEBRIDGE, ANTRIM, BT41 3SF2016-05-05
100 MIDDLE PARK ROAD, CUSHENDALL, ANTRIM, BT44 0FH, NORTHERN IRELAND2013-10-01

Among its peers

No.8 of the largest manufacture of other chemical products not elsewhere classified companies in Belfast →

Competitors Belfast

This company ranks 8 among manufacture of other chemical products not elsewhere classified in Belfast.

Full league table →

The class of 2012

21%

of the 492,231 companies incorporated in 2012 are still active today; 76% have since been dissolved.

A fact about the year, not a forecast for this company.